Page last updated: 2024-08-23

pizotyline and Weight Gain

pizotyline has been researched along with Weight Gain in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dainese, F; Maggioni, F; Mainardi, F; Ruffatti, S; Zanchin, G	1
Anand, B; Briars, GL; Kelly, AM; Travis, SE	1
Barnes, D; Cleland, PG; Elrington, GM; Loizou, LA; Rawes, GD	1
Peters, G; Swiergiel, AH	1

Trials

2 trial(s) available for pizotyline and Weight Gain

Article	Year
Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up. The journal of headache and pain, 2005, Volume: 6, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Anticonvulsants; Atenolol; Cyclohexanecarboxylic Acids; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Pizotyline; Propranolol; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil; Weight Gain	2005
Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. European neurology, 1997, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Pizotyline; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Weight Gain	1997

Article

Year

Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.

The journal of headache and pain, 2005, Volume: 6, Issue:4

Topics: Adrenergic beta-Antagonists; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Anticonvulsants; Atenolol; Cyclohexanecarboxylic Acids; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Pizotyline; Propranolol; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil; Weight Gain

2005

Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.

European neurology, 1997, Volume: 38, Issue:1

Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Pizotyline; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Weight Gain

1997

Other Studies

2 other study(ies) available for pizotyline and Weight Gain

Article	Year
Weight gain with pizotifen therapy. Archives of disease in childhood, 2008, Volume: 93, Issue:7 Topics: Analgesics, Non-Narcotic; Body Height; Child; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pizotyline; Retrospective Studies; Serotonin Antagonists; Treatment Outcome; Weight Gain	2008
Failure of serotonin antagonist pizotifen to stimulate feeding or weight gain in free-feeding rats. Pharmacology, biochemistry, and behavior, 1990, Volume: 35, Issue:1 Topics: Animals; Appetite; Diet; Drinking Behavior; Energy Metabolism; Feeding Behavior; Male; Pizotyline; Rats; Rats, Inbred Strains; Thiophenes; Weight Gain	1990